LP343295-4
Pibrentasvir
Active
Description
Pibrentasvir is a hepatitis C virus (HCV) NS5A protein inhibitor. As of 2019, it is available in the U.S. in combination with glecaprevir, an HCV NS3/NS4A protease inhibitor. The combination drug has high efficacy in treating patients with chronic HCV infection for HCV genotypes 1-6 ("pangenotypic"). PMID: 30977945 Source: Regenstrief LOINC
Basic Part Properties
- Part Display Name
- Pibrentasvir
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2019-04-23
- Construct for LOINC Short Name
- Pibrentasvir
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP343295-4 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP343295-4
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 哌仑他韦 Synonyms: CAS 1353900-92-1; |
| it-IT | Italian (Italy) | Pibrentasvir |
| es-ES | Spanish (Spain) | Pibrentasvir |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright